Industry lining up lobbyists to fight comparative effectiveness

| No Comments

Leave a comment

My policy on comments

I'm adopting the policy of a blog I admire: “Comments are great; obnoxious comments get deleted. Deal." I also won’t post profanity, product pitches, or anything from anyone who doesn’t list what appears to be an actual e-mail address.


About this Entry

This page contains a single entry by Gary Schwitzer published on April 21, 2009 7:48 AM.

Vague and vapid CBS segment on the pill was the previous entry in this blog.

How will the FDA regulate drug promotion via blog, podcast, social network, etc.? is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Archives

Pages

Wikio - Top of the Blogs - Health

Add to Technorati Favorites